Jim Simons Pulmonx Corp Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 301,410 shares of LUNG stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

301,410

Previous 266,610 13.05%

Holding current value

$2.49 Million

Previous $2.47 Million 22.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.77 - $9.82 $200,795 - $341,736	34,800 Added 13.05%	301,410 $1.91 Million
Q1 2024 May 13, 2024	BUY	$8.71 - $14.65 $622,303 - $1.05 Million	71,447 Added 36.61%	266,610 $2.47 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $13.14 $924,337 - $1.54 Million	117,153 Added 150.18%	195,163 $2.49 Million
Q3 2023 Nov 14, 2023	SELL	$9.88 - $14.0 $142,173 - $201,460	-14,390 Reduced 15.57%	78,010 $806,000
Q2 2023 Aug 11, 2023	SELL	$10.78 - $13.65 $1.1 Million - $1.4 Million	-102,445 Reduced 52.58%	92,400 $1.21 Million
Q1 2023 May 12, 2023	BUY	$7.49 - $12.54 $1.32 Million - $2.22 Million	176,803 Added 979.95%	194,845 $2.18 Million
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $88,766 - $313,028	18,042 New	18,042 $152,000
Q2 2022 Aug 12, 2022	SELL	$14.0 - $27.95 $1.14 Million - $2.28 Million	-81,600 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $1.52 Million - $2.56 Million	-71,700 Reduced 46.77%	81,600 $2.02 Million
Q4 2021 Feb 11, 2022	BUY	$29.72 - $45.1 $1.88 Million - $2.85 Million	63,200 Added 70.14%	153,300 $4.92 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $2.22 Million - $2.75 Million	61,800 Added 218.37%	90,100 $3.24 Million
Q2 2021 Aug 13, 2021	BUY	$37.61 - $48.0 $1.06 Million - $1.36 Million	28,300 New	28,300 $1.25 Million

Others Institutions Holding LUNG

# of Institutions

116

Shares Held

30.6M

Call Options Held

400

Put Options Held

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $308M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account